Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Meheco Group CoSHSE:600056 +1.45%63 Net Current Asset Value is ¥1.89 as of Mar. 2026, which is 100% below its 10-year median of 6.76. GuruFocus rates SHSE:600056 with a GF Score™ of 63/100 and a GF Value™ of ¥10.47 (Fairly Valued). The stock has 6 warning signs investors should review. Among 75 Medical Distribution companies, China Meheco Group Co ranks worse than 68% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
China Meheco Group Co's net current asset value per share for the quarter that ended in Mar. 2026 was ¥1.89.
The historical rank and industry rank for China Meheco Group Co's Net Current Asset Value or its related term are showing as below:
SHSE:600056'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.37 Med: 6.76 Max: 22.39
Current: 5.17
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of China Meheco Group Co was 22.39. The lowest was 3.37. And the median was 6.76.
SHSE:600056's Price-to-Net-Current-Asset-Value is ranked worse than 68% of 75
companies
in the Medical Distribution industry
Industry Median: 3.23
vs SHSE:600056: 5.17
China Meheco Group Co (SHSE:600056) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
China Meheco Group Co Net Current Asset Value Related Terms
China Meheco Group Co Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for China Meheco Group Co's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Meheco Group Co Net Current Asset Value Chart
SHSE:600056 vs MCK, CAH, COR: Net Current Asset Value Comparison
For the Medical Distribution subindustry, China Meheco Group Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Meheco Group Co Price-to-Net-Current-Asset-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where China Meheco Group Co's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ¥1.89 mean?
China Meheco Group Co (SHSE:600056) has a Net Current Asset Value of ¥1.89 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on China Meheco Group Co and its competitors. This is 72% below median its historical median of 6.76. Over the past decade, China Meheco Group Co's Net Current Asset Value has ranged from 3.37 to 22.39. According to the industry distribution chart, China Meheco Group Co ranks #51 out of 75 companies in the Medical Distribution industry, placing it in the top 68%.
Is China Meheco Group Co's Net Current Asset Value too high?
China Meheco Group Co's current Net Current Asset Value of ¥1.89 is 72% below median its 10-year median of 6.76. Over the past 10 years, this metric has ranged from a low of 3.37 to a high of 22.39. Based on the distribution chart, China Meheco Group Co ranks #51 out of 75 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, China Meheco Group Co has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's Net Current Asset Value compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, China Meheco Group Co ranks #51 out of 75 companies for Net Current Asset Value. This places China Meheco Group Co in the lower half of its industry. The industry median Net Current Asset Value is 3.23. Historically, China Meheco Group Co's own Net Current Asset Value has ranged from 3.37 to 22.39 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Distribution company?
The median Net Current Asset Value among Medical Distribution companies is 3.23, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on China Meheco Group Co and its competitors. For the Medical Distribution industry, the median Net Current Asset Value is 3.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Meheco Group Co's current Net Current Asset Value is ¥1.89, which is 72% below median its own 10-year median of 6.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Fairly Valued. The stock's GF Value™ is ¥10.47, compared to a current price of ¥9.78 — trading 6.6% below its estimated fair value. The current Net Current Asset Value is ¥1.89, which is 72% below median its 10-year median of 6.76. China Meheco Group Co's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current Net Current Asset Value is ¥1.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?
Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued.
The current stock price of ¥9.78 is trading 6.6% below its estimated GF Value™ of ¥10.47.
GuruFocus considers China Meheco Group Co to be Fairly Valued.
Key valuation signals for SHSE:600056:
Net Current Asset Value: ¥1.89 (72% below median its 10-year median of 6.76)
GF Value™: ¥10.47 vs. price of ¥9.78 (6.6% below fair value)
No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
63GF Score
Get the complete analysis for SHSE:600056
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600056 has been successfully added to your 
